The drugmaker is seeking authorization for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping the shot on track to go into use in the U.S. by year’s end, alongside Pfizer and BioNTech’s.
Read More
The drugmaker is seeking authorization for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping the shot on track to go into use in the U.S. by year’s end, alongside Pfizer and BioNTech’s.
Read More
Tags:
Categories:
Comments are closed